Ben Richardson, CEO at SulNOx, confident they can cost-effectively decarbonise commercial shipping. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHONY.L Regulatory News (HONY)

  • There is currently no data for HONY

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

NAV and Monthly Update - February 2021

1 Apr 2021 07:00

RNS Number : 2016U
Honeycomb Investment Trust PLC
01 April 2021
 

NOT FOR PUBLICATION, DISTRIBUTION OR RELEASE, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, ANY MEMBER STATE OF THE EUROPEAN ECONOMIC AREA (OTHER THAN THE UNITED KINGDOM), CANADA, AUSTRALIA, THE REPUBLIC OF SOUTH AFRICA OR JAPAN OR ANY OTHER JURISDICTION IN WHICH THE DISTRIBUTION OR RELEASE WOULD BE UNLAWFUL

1 April 2021

Honeycomb Investment Trust plc

Honeycomb Investment Trust plc (the "Company" or "Honeycomb") announces that the Investment Manager's monthly factsheet for 28 February 2021 is now available on its website at http://www.honeycombplc.com.

Net Asset Value per Share

The Company announces that its unaudited Net Asset Value ("NAV") per share as at 28 February 2021 on a cum-income basis was 1,026.4 pence, based on a NAV of £361.9 million, and on an ex-income basis was 1,017.8 pence, based on a NAV of £358.9 million. The NAVs have been calculated by Apex Fund Services (UK) Ltd.

This represents a NAV return of 0.64% for the month of February, which is equivalent to 8.3% per annum.

 

Portfolio Performance

Net Investment Assets increased in the month by £22m, to £593m, driven by drawdowns on existing senior facilities to borrowers across the SME and property sectors.

The Company's ability to continue to deliver uninterrupted strong performance during Covid-19 has demonstrated the portfolio's strong income generation together with downside protection through structural seniority and asset backing with an increasing proportion with real estate backing where the Investment Manager sees significant opportunity.

Pipeline & Market Commentary

The current pipeline of new potential investments is particularly strong, and the Investment Manager has identified even more attractive lending opportunities as the Covid-19 pandemic accelerates the structural challenges facing traditional banks.

As the mainstream banks increasingly focus on only vanilla product sets, the non-bank lending sector is increasingly critical to support local communities through financing SMEs, developing affordable housing, improving the energy efficiency of property, and going forward transportation, creating employment and driving financial inclusion. As the population becomes more engaged in living their lives on a sustainable basis, these lending products enable real people to have real positive impact in their daily lives.

The Company has a near term pipeline of c.£2.7billion to deploy capital in excess of its return targets and, the Investment Manager see significant scope to grow the net assets of Honeycomb over time. To that end, the Board continues to focus on its discount management and to improve the liquidity of the shares.

With the government backed Coronavirus Business Interruption Loan Scheme ("CBILS") being replaced by the Recovery Loan Scheme ("RLS"), the Manager believes opportunities to continue support lending to SMEs through government backed schemes offer compelling risk-adjusted returns for shareholders. To date, the Company has supported CBILS lending and expects opportunities to deploy further capital supporting RLS lending

 

This document is made available for information purposes only and does not contain any representations or constitute an offer to sell or the solicitation of an offer to acquire or subscribe for any securities of the Company. All investments are subject to risk. Prospective investors are advised to seek expert legal, financial, tax and other professional advice before making any investment decision. The value of investments may fluctuate and past performance is no guarantee of future results. 

For further information about this announcement please contact:

Pollen Street Capital - Investment Manager

Matthew Potter / Julian Dale: +44 (0)20 3728 6750

Liberum Capital Limited - Joint Broker

Chris Clarke / Louis Davies: +44 (0)20 3100 2000 

Cenkos Securities plc - Joint Broker

Justin Zawoda-Martin / Rob Naylor: +44 (0)20 7397 8900

Link Company Matters Limited - Corporate Secretary

Paul Johnston: +44 (0)20 7954 9552

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NAVFZGFFVMVGMZM
Date   Source Headline
27th Jan 20206:26 pmRNSResult of Buy-Back and total voting rights
27th Jan 20204:08 pmRNSProposed Share Trade and Share Buy-Back
23rd Jan 20207:01 amRNSMonthly Update - December 2019
23rd Jan 20207:00 amRNSNet Asset Value(s)
20th Dec 20197:01 amRNSMonthly Update - November 2019
20th Dec 20197:00 amRNSNet Asset Value(s)
16th Dec 20191:51 pmRNSResult of General Meeting
29th Nov 20197:00 amRNSCircular and Notice of General Meeting
27th Nov 20197:01 amRNSMonthly Update - October 2019
27th Nov 20197:00 amRNSNet Asset Value(s)
19th Nov 20194:13 pmRNSHolding(s) in Company
8th Nov 20197:00 amRNSDividend Declaration
21st Oct 20197:01 amRNSMonthly Update - September 2019
21st Oct 20197:00 amRNSNet Asset Value(s)
30th Sep 20197:01 amRNSMonthly Update - August 2019
30th Sep 20197:00 amRNSNet Asset Value(s)
10th Sep 20197:00 amRNSHalf-year Report 2019
5th Sep 20193:02 pmRNSDividend Declaration
21st Aug 20197:01 amRNSMonthly Update - July 2019
21st Aug 20197:00 amRNSNet Asset Value(s)
12th Aug 20192:51 pmRNSPublication of Suppl.Prospcts
7th Aug 20195:13 pmRNSDirector/PDMR Shareholding
25th Jul 20197:01 amRNSMonthly Update - June 2019
25th Jul 20197:00 amRNSNet Asset Value(s)
25th Jun 201910:10 amRNSMonthly Update - 31 May 2019
25th Jun 201910:04 amRNSNet Asset Value(s)
14th Jun 20197:00 amRNSDirectorate Change
6th Jun 20195:33 pmRNSResult of AGM
21st May 20197:01 amRNSMonthly Update - 30 April 2019
21st May 20197:00 amRNSNet Asset Value(s)
3rd May 20192:46 pmRNSNotice of Annual Report & Director Resignation
29th Apr 20197:00 amRNSDividend Declaration
29th Apr 20197:00 amRNSAnnual Report and Audited Financial Statements
26th Apr 20197:01 amRNSMonthly Update - 31 March 2019
26th Apr 20197:00 amRNSNet Asset Value(s)
21st Mar 20197:01 amRNSMonthly Update - 28 February 2019
21st Mar 20197:00 amRNSNet Asset Value(s)
22nd Feb 20197:02 amRNSMonthly Update - 31 January 2019
22nd Feb 20197:01 amRNSDividend Declaration
22nd Feb 20197:00 amRNSNet Asset Value(s)
29th Jan 20197:01 amRNSFact Sheet December 2018
29th Jan 20197:00 amRNSNet Asset Value(s)
21st Dec 201812:49 pmRNSPlacing Programme: publication of prospectus
21st Dec 20187:01 amRNSMonthly Update - 30 November 2018
21st Dec 20187:00 amRNSNet Asset Value - 30 November 2018
22nd Nov 20187:01 amRNSMonthly Update - 31 October 2018
22nd Nov 20187:00 amRNSNet Asset Value - 31 October 2018
16th Nov 20187:00 amRNSDividend Declaration
23rd Oct 20187:01 amRNSMonthly Update - 30 September 2018
23rd Oct 20187:00 amRNSNet Asset Value - 30 September 2018

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.